HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joo-Won Jeong Selected Research

PD 168368

9/2016Neuromedin B receptor antagonism inhibits migration, invasion, and epithelial-mesenchymal transition of breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joo-Won Jeong Research Topics

Disease

25Neoplasms (Cancer)
11/2021 - 01/2003
17Hypoxia (Hypoxemia)
09/2021 - 01/2002
6Parkinson Disease (Parkinson's Disease)
02/2018 - 01/2009
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2021 - 01/2008
3Neuroblastoma
09/2018 - 01/2009
3Neoplasm Metastasis (Metastasis)
09/2016 - 10/2006
3Lung Neoplasms (Lung Cancer)
11/2014 - 01/2008
2Adenocarcinoma
09/2018 - 09/2007
2Neurodegenerative Diseases (Neurodegenerative Disease)
02/2018 - 01/2009
2Colonic Neoplasms (Colon Cancer)
05/2017 - 03/2010
2Ischemia
10/2015 - 01/2014
2Carcinogenesis
04/2013 - 09/2007
2Hepatocellular Carcinoma (Hepatoma)
06/2006 - 02/2004
1Glioblastoma (Glioblastoma Multiforme)
11/2021
1Peripheral Arterial Disease
01/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2018
1Breast Neoplasms (Breast Cancer)
09/2016
1Inflammation (Inflammations)
11/2015
1Neuroinflammatory Diseases
11/2015
1Vascular Diseases (Vascular Disease)
10/2015
1Necrosis
10/2015
1Brain Ischemia (Cerebral Ischemia)
01/2014
1Diabetes Mellitus
04/2013
1Wounds and Injuries (Trauma)
04/2013
1Cardiovascular Diseases (Cardiovascular Disease)
04/2013
1Pheochromocytoma
10/2011
1Thymoma (Thymic Carcinoma)
06/2010
1Parkinsonian Disorders (Parkinsonism)
01/2009
1Infections
01/2008
1Fibrosarcoma
04/2007

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
09/2021 - 02/2004
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015 - 01/2002
7Oxygen (Dioxygen)IBA
11/2021 - 01/2002
41- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2018 - 01/2010
4Reactive Oxygen Species (Oxygen Radicals)IBA
05/2017 - 03/2010
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2015 - 01/2003
3Pharmaceutical PreparationsIBA
09/2018 - 11/2015
3zingeroneIBA
09/2018 - 11/2015
3Neuroprotective AgentsIBA
02/2018 - 04/2010
3Exenatide (Byetta)FDA Link
10/2015 - 04/2013
3MelatoninIBA
11/2014 - 03/2010
2Tyrosine Kinase InhibitorsIBA
09/2021 - 10/2014
2ErbB Receptors (EGF Receptor)IBA
09/2021 - 10/2014
2Gefitinib (Iressa)FDA Link
09/2021 - 10/2014
2Therapeutic UsesIBA
09/2018 - 07/2016
2cinnamaldehyde (cinnamic aldehyde)FDA Link
02/2018 - 11/2015
21-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
01/2018 - 01/2009
2AMP-Activated Protein KinasesIBA
01/2018 - 01/2010
2Hypoxia-Inducible Factor 1IBA
11/2015 - 01/2008
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2014 - 04/2010
2Biological ProductsIBA
06/2010 - 02/2004
2Transcription Factors (Transcription Factor)IBA
03/2010 - 01/2002
2Okadaic AcidIBA
04/2009 - 01/2009
1beta-Arrestin 1IBA
11/2021
1Antineoplastic Agents (Antineoplastics)IBA
09/2021
1Histones (Histone)IBA
09/2018
1Cell Cycle ProteinsIBA
09/2018
1Cyclin D1IBA
09/2018
1Phosphotransferases (Kinase)IBA
08/2018
1Messenger RNA (mRNA)IBA
01/2018
1Interleukin-8 (Interleukin 8)IBA
01/2018
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2018
1Plasma GasesIBA
05/2017
1Bombesin Receptors (Bombesin Receptor)IBA
09/2016
1Cadherins (E-Cadherin)IBA
09/2016
1VimentinIBA
09/2016
1PD 168368IBA
09/2016
1Matrix Metalloproteinases (MMPs)IBA
07/2016
1SirtuinsIBA
04/2016
1Sirtuin 2IBA
04/2016
1Estrogen ReceptorsIBA
11/2014
118-dehydroxyl-17-demethoxyreblastatinIBA
10/2014
1geldanamycinIBA
10/2014
1salicinIBA
08/2014
1fluoro jadeIBA
01/2014
1Glucagon-Like Peptide-1 ReceptorIBA
01/2014
1Glycyrrhizic Acid (Glycyrrhizin)IBA
06/2013
1Glucagon-Like Peptides (Enteroglucagon)IBA
04/2013
1p-coumaric acidIBA
03/2013
1Hemoglobins (Hemoglobin)IBA
03/2013
1Nicotinamide PhosphoribosyltransferaseIBA
10/2011
1coenzyme Q10 (CoQ10)IBA
01/2011
1Peptide Hydrolases (Proteases)FDA Link
06/2010
1Membrane Proteins (Integral Membrane Proteins)IBA
06/2010
1AcetyltransferasesIBA
06/2010
1matriptaseIBA
06/2010
1matrigelIBA
06/2010
1ethyl pyruvateIBA
04/2010
1Conditioned Culture MediaIBA
03/2010
1AntioxidantsIBA
03/2010
1Dopamine (Intropin)FDA LinkGeneric
12/2009
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
01/2008
1Proteasome InhibitorsIBA
01/2008
1deguelinIBA
01/2008
1Protein Kinase C-deltaIBA
09/2007
1Butyric Acid (Butanoic Acid)IBA
04/2007
1Histone Deacetylase InhibitorsIBA
04/2007
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
06/2006

Therapy/Procedure

8Therapeutics
01/2020 - 01/2003
1Drug Therapy (Chemotherapy)
09/2018